文献速递细胞病理与分子病理神经与头颈病理

唾液腺分泌性癌:一项国际多中心细胞病理学研究

Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.
PubMed 文献 · Cancer Cytopathol · 2022-04-06

该研究回顾性分析了来自4个国家12家学术机构的40例经组织学确诊的唾液腺分泌性癌细针穿刺(FNA)病例,总结其细胞形态学、免疫表型及分子特征,并依据米兰系统进行分类。结果显示FNA诊断恶性者占50%,常用免疫标记S100、mammaglobin、GATA-3等阳性,ETV6-NTRK3融合检出率高,提示熟悉这些特征可提高诊断准确性。

要点

  • 唾液腺分泌性癌FNA细胞学以大型圆形细胞、胞内空泡或颗粒、核仁明显为特征,常呈簇状、乳头状或散在分布。
  • 免疫组化S100、mammaglobin、GATA-3、AE1/AE3和vimentin阳性有助于诊断。
  • ETV6-NTRK3融合检测可作为分子确诊依据,本组检出率极高。

核心结论

  • 熟悉唾液腺分泌性癌的细胞形态学及免疫/分子特征可提高FNA诊断准确性。

研究设计与样本

  • 回顾性收集美国、意大利、芬兰和巴西12家学术机构经组织学确诊的唾液腺分泌性癌FNA病例,共40例。

主要发现

  • 患者男女比例为14:26,平均年龄52岁(范围13-80岁),最常见原发部位为腮腺(30/40)。
  • 9例出现区域淋巴结转移,4例出现远处转移(脑、肝、肺、纵隔),2例死于疾病。
  • FNA涂片细胞丰富,主要为大型圆形细胞,含胞内空泡或颗粒,核圆至卵圆、轮廓光滑、异型性小、核仁明显,排列成簇、乳头状及单细胞。
  • 背景不定,含炎细胞、黏液或蛋白样物质。
  • 米兰系统诊断分类:恶性19/38(50%),可疑恶性10/38(26%),意义不明的涎腺肿瘤7/38(18%),非典型2/38(6%);其中2例恶性(2/40,5%)为转移。

关键数值与推荐

  • 免疫组化阳性率:S100 23/24,mammaglobin 18/18,GATA-3 13/13,AE1/AE3 7/7,vimentin 6/6。
  • ETV6-NTRK3融合检出32/33(FISH n=32,NGS n=1)。

临床怎么用

  • 对涎腺FNA出现大型圆形细胞、胞内空泡/颗粒及乳头状结构时,应想到分泌性癌可能。
  • 联合S100、mammaglobin、GATA-3等免疫组化及ETV6-NTRK3融合检测可辅助确诊。
  • 依据米兰系统分类,多数病例可归为恶性或可疑恶性,有助于临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Secretory carcinoma (SC) of the salivary gland is a rare entity with limited published literature on cytomorphology. The authors present the largest cohort to date of SC fine-needle aspiration (FNA) cases. METHODS: FNA cases of histologically confirmed SC were retrospectively retrieved from 12 academic institutions in the United States, Italy, Finland, and Brazil. The collated data included patient demographics, imaging findings, cytopathologic diagnoses according to the Milan System for Reporting Salivary Gland Cytopathology, cytomorphologic characteristics, and immunohistochemical/molecular profiles. RESULTS: In total, 40 SCs were identified (male-to-female ratio, 14:26) in patients with a mean age of 52 years (age range, 13-80 years). Ultrasound imagining revealed a hypoechoic, ovoid, poorly defined, or lobulated mass. The most common primary site was the parotid gland (30 of 40 tumors). Regional lymph node metastasis (9 patients) and distant metastasis (4 patients; brain, liver, lungs, and mediastinum) were noted. Two patients died of disease. FNA smears were cellular and demonstrated mainly large, round cells with intracytoplasmic vacuoles or granules and round-to-oval nuclei with smooth nuclear contour, minimal irregularities, and prominent nucleoli arranged predominantly in clusters, papillary formations, and single cells. The background was variable and contained inflammatory cells, mucin, or proteinaceous material. The diagnoses were malignant (19 of 38 tumors; 50%), suspicious for malignancy (10 of 38 tumors; 26%), salivary gland neoplasm of uncertain malignant potential (7 of 38 tumors; 18%), and atypia of undetermined significance (2 of 38 tumors; 6%) according to the Milan System for Reporting Salivary Gland Cytopathology. Two malignant cases (2 of 40 tumors; 5%) were metastases. The neoplastic cells were immunoreactive for S100 (23 of 24 tumors), mammaglobin (18 of 18 tumors), GATA-3 (13 of 13 tumors), AE1/AE3 (7 of 7 tumors), and vimentin (6 of 6 tumors). ETV6-NTRK3 fusion was detected in 32 of 33 tumors by fluorescence in situ hybridization (n = 32) and next-generation sequencing (n = 1). CONCLUSIONS: Familiarity with cytomorphologic features and the immunohistochemical/molecular profile of SC can enhance diagnostic accuracy.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Wiles AB, Gabrielson M, Baloch ZW, et al. Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study. Cancer Cytopathol. 2022. PMID: 35385604. doi:10.1002/cncy.22574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。